The economic impact of pharmacist intervention during pandemics

References

• Bragazzi NL, Mansour M, Bonsignore A, et al. The role of hospital and community pharmacists in the management of COVID-19: towards an expanded definition of the roles, responsibilities, and duties of the pharmacist. Pharm (Basel, Switzerland). 2020 Aug;8(3):140. doi: 10.3390/pharmacy8030140
   PubMedGoogle Scholar
• Ohannessian R, Duong TA, Odone A. Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a call to action. JMIR Public Heal Surveill. 2020 Apr;6(2):e18810. doi: 10.2196/18810
   PubMedGoogle Scholar
• Graves JA, Baig K, Buntin M. The financial effects and consequences of COVID-19: a gathering storm. JAMA. 2021;326(19):1909–1910. doi: 10.1001/jama.2021.18863
   PubMed Web of Science ®Google Scholar
• Aruru M, Truong HA, Clark S. Pharmacy emergency preparedness and response (PEPR): a proposed framework for expanding pharmacy professionals’ roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond. Res Soc Adm Pharm. 2020;17(1):1967–1977. doi: 10.1016/j.sapharm.2020.04.002
   PubMed Web of Science ®Google Scholar
• Hess K, Bach A, Won K, et al. Community pharmacists roles during the COVID-19 pandemic. J Pharm Pract. 2022;35(3):469–476. InternetAvailable from. doi: 10.1177/0897190020980626
   PubMed Web of Science ®Google Scholar
• Hedima EW, Adeyemi MS, Ikunaiye NY. Community pharmacists: on the frontline of health service against COVID-19 in LMICs. Res Soc Adm Pharm. 2021;17(1):1964–1966. doi: 10.1016/j.sapharm.2020.04.013
   PubMed Web of Science ®Google Scholar
• Mallhi TH, Liaqat A, Abid A, et al. Multilevel engagements of pharmacists during the COVID-19 pandemic: the way forward. Front Public Health. 2020;8:561924. doi: 10.3389/fpubh.2020.561924
   PubMed Web of Science ®Google Scholar
• Li M, Razaki H, Mui V, et al. The pivotal role of pharmacists during the 2019 coronavirus pandemic. J Am Pharm Assoc. 2020;60(6):e73–5. doi: 10.1016/j.japh.2020.05.017
   Google Scholar
• Ibrahim OM, Ibrahim RM, Meslamani AA, et al. Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors. J Telemed Telecare. 2020. doi: 10.1177/1357633X20964347
   PubMed Web of Science ®Google Scholar
• Al Mazrouei N, Ibrahim RM, Al Meslamani AZ, et al. The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge. Int J Pharm Pract. 2020;29(2):137–144. doi: 10.1093/ijpp/riaa003
   Web of Science ®Google Scholar
• Strand MA, Bratberg J, Eukel H, et al. Community pharmacists’ contributions to disease management during the COVID-19 pandemic. Prev Chronic Dis. 2020 Jul;17:E69. doi: 10.5888/pcd17.200317
   PubMed Web of Science ®Google Scholar
• Al-Badriyeh D, Kaddoura R, AlMaraghi F, et al. Impact of clinical pharmacist interventions on economic outcomes in a cardiology setting in Qatar. Curr Probl Cardiol. 2023 Sep;48(9):101838. doi: 10.1016/j.cpcardiol.2023.101838
   PubMed Web of Science ®Google Scholar
• Al-Quteimat O, Siddiqui M, Hussein L, et al. Analysis of pharmacist interventions in adult COVID-19 patients admitted to a tertiary care hospital. J Pharm Pract. 2023;36(3):572–578. doi: 10.1177/08971900211065536
   PubMed Web of Science ®Google Scholar
• Lehnbom EC, Berbakov ME, Hoffins EL, et al. Elevating safe use of over-the-counter medications in older adults: a narrative review of pharmacy involved interventions and recommendations for improvement. Drugs Aging. 2023;40(7):621–632. doi: 10.1007/s40266-023-01041-5
   PubMed Web of Science ®Google Scholar
• Yung E, McNicol M, Lewis D, et al. Economic impact of pharmacist interventions in pediatric ambulatory care clinics. J Am Pharm Assoc. 2021;61(2):198–205.e1. doi: 10.1016/j.japh.2020.11.009
   Google Scholar
• Kretchy IA, Asiedu-Danso M, Kretchy JP. Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low-and middle-income countries. Res Social Adm Pharm. 2021 Jan;17(1):2023–2026. doi: 10.1016/j.sapharm.2020.04.007
   PubMed Web of Science ®Google Scholar
• Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7(3):35–44. doi: 10.2147/RMHP.S19801
   PubMedGoogle Scholar
• Leiz M, Pfeuffer N, Rehner L, et al. Telemedicine as a tool to improve medicine adherence in patients with affective disorders - a systematic literature review. Patient Prefer Adherence. 2022;16:3441–3463. doi: 10.2147/PPA.S388106
   PubMed Web of Science ®Google Scholar
• Ventola CL. The drug shortage crisis in the United States: causes, impact, and management strategies. P T. 2011 Nov;36(11):740–757.
   PubMedGoogle Scholar
• Elbeddini A, Hooda N, Yang L. Role of Canadian pharmacists in managing drug shortage concerns amid the COVID-19 pandemic. Can Pharm J (Ott). 2020;153(4):198–203. doi: 10.1177/1715163520929387
   PubMedGoogle Scholar
• The Federal retail pharmacy program for COVID-19 vaccination [Internet]. 2023 [cited 2023 Jul 25]. Available from: https://www.cdc.gov/vaccines/covid-19/retail-pharmacy-program/index.html
   Google Scholar
• Bartsch SM, Taitel MS, V DJ, et al. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic. Vaccine. 2018;36(46):7054–7063. doi: 10.1016/j.vaccine.2018.09.040
   PubMed Web of Science ®Google Scholar
• Singhal PK, Zhang D. Costs of adult vaccination in medical settings and pharmacies: an observational study. J Manag Care Spec Pharm. 2014 Sep;20(9):930–936. doi: 10.18553/jmcp.2014.20.9.930
   PubMed Web of Science ®Google Scholar
• Wu C, Bell CM, Wodchis WP. Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study. Drug Saf. 2012 Sep;35(9):769–781. doi: 10.1007/BF03261973
   PubMed Web of Science ®Google Scholar
• Morgan SG, Hunt J, Rioux J, et al. Frequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study. C Open. 2016;4(2):E346–51. doi: 10.9778/cmajo.20150131
   PubMedGoogle Scholar
• Pickett B, Shin TR, Norton M. Utilizing clinical pharmacists and a medication assistance program to improve medication access for indigent and underserved patients in primary care. Explor Res Clin Soc Pharm. 2023;9:100211. doi: 10.1016/j.rcsop.2022.100211.
   PubMedGoogle Scholar
• Grant A, Rowe L, Kennie-Kaulbach N, et al. Increased self-reported pharmacist prescribing during the COVID-19 pandemic: using the theoretical domains framework to identify barriers and facilitators to prescribing. Res Social Adm Pharm. 2023 Jan;19(1):133–143. doi: 10.1016/j.sapharm.2022.08.014
   PubMed Web of Science ®Google Scholar
• Elbeddini A, Yeats A. Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine. J Pharm Policy Pract. 2020;13(1):23. doi: 10.1186/s40545-020-00229-z
   PubMed Web of Science ®Google Scholar